ClinicalTrials.gov: Linking Patients to Medical Research
ClinicalTrials.gov is a system designed to provide patients, families, and other members of the public with easy access to Web-based information about clinical research studies. The system owes its creation to a section of the Food and Drug Administration Modernization Act (1997), which charged the National Institutes of Health (NIH) with creating such a resource. The scope of this legislation is broad, requiring publicly available information on all clinical trials—whether federally or privately funded—for experimental treatments for serious or life-threatening diseases and conditions. On behalf of all NIH Institutes, the National Library of Medicine (NLM) developed ClinicalTrials.gov and made it available to the public in February 2000.
KeywordsLeukemia Anemia Cyclophosphamide Filgrastim Busulfan
Unable to display preview. Download preview PDF.
- FDA Modernization Act of 1997, Public Law 105-115, Section 113. Information Program on Clinical Trials for Serious or Life-Threatening Diseases, http://www.fda.gov/cder/guidance/105-115.htm. Accessed 12/20/2000.Google Scholar
- International Collaborative Group on Clinical Trial Registries. 1993. Position Paper and Consensus Recommendations on Clinical Trial Registries. Clinical Trials Metaanalysis 28:255–266.Google Scholar
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. 1996. ICH Harmonized Tripartite Guideline. Guideline for Good Clinical Practice, 30–33. http://www.ifpma.org/pdfifpma/e6.pdf. Accessed 12/20/2000.Google Scholar
- Spilker B. 1996. Guide to Clinical Trials. Philadelphia: Lippincott-Raven. 816–819.Google Scholar
- UMLS Information, http://umlsinfo.nlm.nih.gov/. Accessed 12/20/2000.Google Scholar